US45329R1095

MORRISVILLE, N.C., Jan. 26, 2021 (GLOBE NEWSWIRE) — Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release

MORRISVILLE, N.C., Jan. 04, 2021 (GLOBE NEWSWIRE) — Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a

Acquisition Enhances Company’s Decentralized Solutions Offering by Strengthening Patient Focus MORRISVILLE, N.C., Dec. 18, 2020 (GLOBE NEWSWIRE) — Syneos Health®

Unique Product Development Model Delivers Accelerated Growth Presentation Begins at 9:00 A.M. ET on Tuesday, December 8 MORRISVILLE, N.C., Dec.

MORRISVILLE, N.C., Dec. 02, 2020 (GLOBE NEWSWIRE) — Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), the only

MORRISVILLE, N.C., Dec. 02, 2020 (GLOBE NEWSWIRE) — Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), the only

MORRISVILLE, N.C., Dec. 01, 2020 (GLOBE NEWSWIRE) — Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), the only

MORRISVILLE, N.C., Dec. 01, 2020 (GLOBE NEWSWIRE) — Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), the only

MORRISVILLE, N.C., Nov. 24, 2020 (GLOBE NEWSWIRE) — Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), the only

MORRISVILLE, N.C., Nov. 18, 2020 (GLOBE NEWSWIRE) — Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), the only